News2022-09-12T16:29:50-05:00
October 29th, 2024|

Baron & Budd Investigates Potential Fraud Activity Among HUBZone-Certified Small Businesses

October 8th, 2018|

HUBZone contractors play key role in policing industry, identifying and reporting potential fraud October 8, 2018, Washington D.C. - Today, the national law firm Baron & Budd [...]

Baron & Budd Investigating Medicare and Medicaid Fraud in Patient Assistance Programs for Specialty Drugs

September 24th, 2018|

Whistleblowers play key role highlighting fraudulent charities that target public insurance programs September 24, 2018 WASHINGTON -- Today, the national law firm Baron & Budd [...]

Baron & Budd Secures $110 Million to Settle Texas Whistleblower Lawsuits Against AstraZeneca for Fraudulently Marketing Seroquel, Crestor

August 8th, 2018|

Suits Alleged Pharmaceutical Giant Illegally Promoted Seroquel Prescriptions for Children, Misrepresented Safety of Crestor August 07, 2018 DALLAS--(BUSINESS WIRE)--Today, the national law firm of Baron & Budd announced [...]

Baron & Budd Secures $13.25 Million to Settle Texas Whistleblower Lawsuit Against Endo Pharmaceuticals for Fraudulently Marketing Lidoderm for Unapproved Uses

August 8th, 2018|

Pharmaceutical Company Allegedly Violated Federal and Texas Medicaid Laws August 01, 2018 DALLAS--(BUSINESS WIRE)--Today, the national law firm of Baron & Budd announced that Endo Pharmaceuticals Inc. (“Endo”) [...]

Baron & Budd Secures Three Additional Settlements with Virginia Defense Contractors for Alleged FCA Violations Totaling $620,000

March 26th, 2018|

Washington, D.C. - The national law firm of Baron & Budd today announced that the U.S. Department of Justice has reached settlements with three additional [...]

Go to Top